薬物によるシグナル伝達分子抑制のメカニズム
Judith S Sebolt-Leopold1, Jessie M English
1Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA.
Nature
|May 26, 2006
まとめ
新しい分子標的がん治療は,非特異的な薬から離れ,パラダイムシフトをもたらします. 複雑な経路をターゲットにするという課題があるにもかかわらず,これらの新興剤は,様々なヒトがんに対して重要な治療的進歩を示しています.
科学分野:
- 腫瘍学 腫瘍学
- 薬理学 薬理学とは
- 分子生物学は分子生物学である.
背景:
- がん治療は,分子的に標的を絞った薬剤へと移行しており,従来の細胞毒薬への依存度を低下させています.
- 特定の分子経路を標的とした新しい抗癌薬の開発は,重要な進歩を表しています.
- がんに関与する複雑な信号伝達経路を理解し,ターゲットにすることが依然として課題です.
研究 の 目的:
- 分子的にターゲティングされた薬剤によって駆動されるがん治療のパラダイムシフトを強調するために.
- 新興抗癌薬の効果的な治療方案の設計における課題と進歩について議論する.
- 新薬の正確な作用機構の不確実性にもかかわらず,新薬の治療的可能性を強調する.
主な方法:
- がん治療における新興分子標的薬剤のレビュー.
- 癌治療に関与する信号伝達経路の分析.
- 新種の抗癌化合物に関連する治療的進歩と課題の評価.
主要な成果:
- 分子標的薬は,健康な細胞の損傷を最小限に抑え,パラダイムシフトを表しています.
- 新世代の抗癌薬の標的の多様性を拡大した.
- ヒトがんの広範なスペクトルにわたって顕著な治療的進歩が観察されました.
結論:
- 新興ターゲティング剤は,がん治療のパラダイムに革命を起こしています.
- 複数の経路を標的とした複雑さにもかかわらず,これらの薬剤はかなりの有効性を示しています.
- 分子メカニズムに関する継続的な研究は,パーソナライズされたがん治療をさらに最適化します.
関連する概念動画
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...


